Myrmecridium flexuosum NUK-21, novel lactose oxidase isolated from Myrmecridium flexuosum NUK-21, and method for conversion of lactose into lactobionic acid by novel lactose oxidase
US10683487B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2018 |
| Grant date | Jun 16, 2020 |
| Priority date | — |
| Expiry date | Sep 4, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/645
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A Myrmecridium flexuosum NUK-21, a novel lactose oxidase isolated from the Myrmecridium flexuosum NUK-21 and a method for conversion of lactose into lactobionic acid (LBA) by the novel lactose oxidase are disclosed herein. The Myrmecridium flexuosum NUK-21 produces high yields of the novel lactose oxidase and the novel lactose oxidase has higher reactivity and specificity of converting lactose into lactobionic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.